tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Technical Analysis

Compare
508 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Y-Mabs Therapeutics’s (YMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Y-Mabs Therapeutics is a Buy.
Y-Mabs Therapeutics’s (YMAB) 20-Day exponential moving average is 4.56, while Y-Mabs Therapeutics’s (YMAB) share price is $4.1, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 50-Day exponential moving average is 5.15, while Y-Mabs Therapeutics’s (YMAB) share price is $4.1, making it a Sell.

Y-Mabs Therapeutics (YMAB) Pivot Points

Apr 27, 2025, 04:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.75
3.83
3.98
4.06
4.21
4.29
4.44
Fibonacci
3.83
3.92
3.97
4.06
4.15
4.20
4.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Y-Mabs Therapeutics (YMAB) Moving Averages

Apr 27, 2025, 04:51 AM
Period
Simple
Exponential
MA5
4.29Sell
4.26Sell
MA10
4.58Sell
4.41Sell
MA20
4.53Sell
4.56Sell
MA50
4.98Sell
5.15Sell
MA100
6.38Sell
6.54Sell
MA200
9.76Sell
9.04Sell
Y-Mabs Therapeutics’s (YMAB) 10-Day exponential moving average is 4.41, while Y-Mabs Therapeutics’s (YMAB) share price is $4.1, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 100-Day exponential moving average is 6.54, while Y-Mabs Therapeutics’s (YMAB) share price is $4.1, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.1 and Y-Mabs Therapeutics’s (YMAB) 50-day simple moving average is 4.98, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.1 and Y-Mabs Therapeutics’s (YMAB) 100-day simple moving average is 6.38, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $4.1 and Y-Mabs Therapeutics’s (YMAB) 200-day simple moving average is 9.76, creating a Sell signal.

Y-Mabs Therapeutics (YMAB) Technical Indicators

Apr 27, 2025, 04:51 AM
Name
Value
Implied Action
RSI (14)
40.35
Neutral
STOCH (9,6)
17.29
Buy
STOCHRSI (14)
17.29
Buy
MACD (12,26)
-0.20
Buy
ADX (14)
21.06
Neutral
Williams %R
-83.75
Buy
CCI (14)
-124.07
Buy
ATR (14)
0.42
-
Ultimate Oscillator
46.31
Neutral
ROC
-9.69
Sell
Y-Mabs Therapeutics’s (YMAB) Relative Strength Index (RSI) is 40.35, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Trend Strength Indicator (ADX) is 21.06, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Commodity Channel Index (CCI) is -124.07, creating a Buy signal.
Y-Mabs Therapeutics’s (YMAB) Price Rate of Change (ROC) is -9.69, creating a Sell signal.

FAQ

Is YMAB a Buy, Hold, or Sell?
Based on YMAB’s technical indicators, YMAB is a Sell.
    What is YMAB’s RSI (14)?
    YMAB’s RSI (14) is 40.35, which suggests YMAB is a Neutral.
      What is YMAB’s MACD?
      YMAB’s MACD is -0.20, which suggests YMAB is a Buy.
        What is YMAB’s 5-day moving average?
        YMAB’s 5-day moving average is 4.29, which suggests YMAB is a Sell.
          What is YMAB’s 20-day moving average?
          YMAB 20-day moving average is 4.53, which suggests YMAB is a Sell.
            What is YMAB’s 50-day moving average?
            YMAB’s 50-day moving average is 4.98, which suggests YMAB is a Sell.
              What is YMAB’s 200-day moving average?
              YMAB’s 200-day moving average is 9.76, which suggests YMAB is a Sell.
                What is YMAB’s Williams % R (14)?
                YMAB’s Williams % R (14) is -83.75, which suggests YMAB is a Buy.
                  What is YMAB’s CCI (14)?
                  YMAB’s CCI (14) is -124.07, which suggests YMAB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis